CV Sciences (CVSI) Free Cash Flow (2011 - 2026)
CV Sciences (CVSI) reported Free Cash Flow of $98000.0 for Q1 2026, up 180.99% on a YoY basis from $34876.5 in Q1 2025, and up 131.72% sequentially from -$309000.0 in Q4 2025.
CV Sciences (CVSI) Free Cash Flow (2011 - 2026) Analysis & Trends
CV Sciences (CVSI) has 16 years of Free Cash Flow data on file, last reported at $98000.0 in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 180.99% year-over-year to $98000.0; the trailing twelve-month figure through Mar 2026 stood at -$290000.0 (up 39.83% YoY), and the FY2025 full-year result was -$509000.0, up 42.09% from the prior year.
- Free Cash Flow grew to $98000.0 in Q1 2026, from -$309000.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $1.4 million in Q2 2023 to a low of -$1.2 million in Q2 2022.
- A 5-year average of -$54235.3 and a median of -$121000.0 in 2025 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow tumbled 542.11% in 2024 and surged 517.54% in 2025, its largest moves.
- Tracing CVSI's Free Cash Flow over 5 years: stood at $210000.0 in 2022, then sank by 154.29% to -$114000.0 in 2023, then slumped by 59.65% to -$182000.0 in 2024, then slumped by 69.78% to -$309000.0 in 2025, then jumped by 131.72% to $98000.0 in 2026.
- Business Quant data shows CVSI's Free Cash Flow at $98000.0 in Q1 2026, -$309000.0 in Q4 2025, and -$317000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn | 98,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98,000.00 |
| Mar 31, 2026 | 98,000.00 |
| Dec 31, 2025 | -309,000.00 |
| Dec 31, 2025 | -309,000.00 |
| Sep 30, 2025 | -317,000.00 |
| Sep 30, 2025 | -317,000.00 |
| Jun 30, 2025 | 238,000.00 |
| Jun 30, 2025 | 238,000.00 |
| Mar 31, 2025 | -121,000.00 |
| Mar 31, 2025 | -121,000.00 |
| Dec 31, 2024 | -182,000.00 |
| Dec 31, 2024 | -182,000.00 |
| Sep 30, 2024 | -122,000.00 |
| Sep 30, 2024 | -122,000.00 |
| Jun 30, 2024 | -57,000.00 |
| Jun 30, 2024 | -57,000.00 |
| Mar 31, 2024 | -518,000.00 |
| Mar 31, 2024 | -518,000.00 |
| Dec 31, 2023 | -114,000.00 |
| Dec 31, 2023 | -114,000.00 |